Medicon Hellas S.A. (ATH:MEDIC)

Market Cap	11.00M
Revenue (ttm)	18.12M
Net Income (ttm)	1.37M
Shares Out	4.42M
EPS (ttm)	0.31
PE Ratio	8.38
Forward PE	n/a
Dividend	0.06 (2.47%)
Ex-Dividend Date	Jul 4, 2025

Volume	4,300
Average Volume	16,665
Open	2.450
Previous Close	2.430
Day's Range	2.420 - 2.490
52-Week Range	1.940 - 2.920
Beta	0.56
RSI	39.53
Earnings Date	Sep 26, 2025

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer system for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calib...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 157
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: MEDIC

Financial Performance

In 2024, Medicon Hellas's revenue was 18.12 million, an increase of 0.03% compared to the previous year's 18.12 million. Earnings were 1.37 million, an increase of 3.38%.